Mulrow, P.J. , Forman, B.H.: The tissue effects of mineralocorticoids . The American Journal of Medicine53: 561, 1972.
2.
Williams, G.H. , Lauler, D.P.: Water, electrolyte, and acid-base disorders in congestive heart failure and hypertension. In " Clinical Disorders of Fluid and ElectrolyteMetabolism". McGraw-Hill Book Co., A Blakistan Publication (edited by Maxwell, M. H., Kleeman, C. R.) pp. 835-872, 1972.
3.
Williams, G.H. , Dluhy, R.G.: Aldosterone biosynthesis-Interrelationship of regulatory factors. The American Journal of Medicine53: 595, 1972.
4.
Laragh, J.H. , Sealey, J.E., Brunner , H.R.: The control of aldosterone secretion in normal and hypertensive man: Abnormal renin aldosterone patterns in low renin hypertension. The American Journal of Medicine53: 649, 1972.
5.
Oparil, S., Haber, E.: The renin angiotensin system. The New England Journal of Medicine291: 389, 1974.
6.
Baumber, J.S. , Davis, J. 0., Johnson, J. A., Witty, R. T.: Increased adrenocortical potassium in association with increased biosynthesis of aldosterone . American Journal of Physiology220: 1094, 1971 .
7.
Gann, D.S., Delea, C.S., Gill, J.R., Jr., Thomas, J.P., Bartter, F.C.: Control of aldosterone secretion by change of body potassium in normal man . American Journal of Physiology207: 104, 1964 .
8.
Bayard, F., Cooke, C.R., Tiller, D.J., Beitins, I.Z., Kowarski, A., Walker, W.G., Migeon, C.J.: The regulation of aldosterone secretion in anephric man. The Journal of Clinical Investigation50: 1585, 1971.
9.
Newton, M.A. , Laragh, J.H.: Effects of glucocorticoid administration on aldosterone excretion and plasma renin in normal subjects in essential hypertension and in primary aldosteronism. Journal of Clinical Endocrinology & Metabolism28: 1014, 1968.
10.
Williams, G.H. , Rose, L.I., Dluhy , R.G., Dingman, J.F., Lauler, D.P.: Aldosterone response to sodium restriction and ACTH stimulation in panhypopituitarism . Journal of Clinical Endocrinology & Metabolism32: 27, 1971.
11.
Mitra, S., Genuth, S.M., Berman, L.B., Vertes, V.: Aldosterone secretion in anephric patients. The New England Journal of Medicine286: 61, 1972.
12.
Kem, D.C., Weinberger, M.H., Gomez-Sanchez, C., Kramer, N.J., Lerman, R., Furuyama, S., Nugent, C.A.: Circadian rhythm of plasma aldosterone concentration in patients with primary aldosteronism. The Journal of Clinical Investigation52: 2272, 1973.
13.
Cain, J.P., Tuck, M.L., Williams, G.H., Dluhy, R.G., Rosenoff, S.H.: The regulation of aldosterone secretion in primary aldosteronism. The American Journal of Medicine53: 627, 1972.
14.
Guyton, A.R.: Physics of blood, blood flow and pressure: Hemodynamics. In " Textbook of Medical Physiology" (W. B. Saunders Co.), pp. 204-217, 1971.
15.
Laragh, J.H. : Vasoconstriction-Volume analysis in treatment of hypertension. Hospital Practice9: 55, 1974.
16.
Gavras, H., Brunner, H.R., Vaughan, E.D., Jr., Laragh, J.H.: Angiotensin-sodium interaction in blood pressure maintenance of renal hypertensive and normotensive rats. Science180: 1369, 1973 .
17.
Davies, D.L. , Schalekamp. M.A., Beevers, D.G., Brown, J.J., Briggs, J.D., Lever, A.F., Medina, A.M., Morton, J.J., Robertson, J.I.S., Tree, M.: Abnormal relation between exchangeable sodium and the renin-angiotensin system in malignant hypertension and in hypertension with chronic renal failure. The Lancet1: 683, 1973.
18.
Lebel, M., Schalekamp, M.A., Beevers, D.G., Brown, J.J., Davies, D.L., Fraser, R., Kremer, D., Lever, A.F., Morton, J.J., Robertson, J.I.S., Tree, M., Wilson, A.: Sodium and the renin-angiotensin system in essential hypertension and mineralocorticoid excess. The Lancet1: 308, 1974.
19.
Brunner, H.R. , Chang, P., Wallach , R., Sealey, J.E., Laragh, J.H.: Angiotensin II vascular receptor: Their avidity in relationship to sodium balance, the autonomic nervous system, and hypertension. Journal of Clinical Investigation51: 58, 1972.
20.
Schalekamp, M.A., Lebel, M., Beevers , D.G., Fraser, R., Kolsters, G., Birkenhager, W.H.: Body-fluid volume in low renin hypertension . The Lancet2: 310, 1974.
21.
Lucas, C.P. , Holzwarth, G.J., Ocobock , R.W., Sozen, T., Stern, M.P., Wood, W.L., Haskell, W.L., Farquhar, J.W.: Disturbed relationship of plasma renin to blood pressure in hypertension. The Lancet2: 1337, 1974.
22.
Luetscher, J.A., Jr., Axelrad , B.J.: Increased aldosterone output during sodium deprivation in normal man. Proc. Sox. Exp. Biol. Med.87: 650, 1954.
23.
Brown, J.J. , Davies, D.L., Doak , P.B., Lever, A.F., Robertson, J.I.S.: Plasma renin in normal pregnancy. The Lancet2: 900, 1963.
Beckerhoff, R., Luetscher, J.A., Wilkinson , R., Gonzales, C., Nokes, G.W.: Plasma renin concentration, activity, and substrate in hypertension induced by oral contraceptives . Journal of Clinical Endocrinology & Metabolism34: 1067, 1972 .
26.
Walters, W.A.W. , Lim, Y.L.: Hemodynamic changes in women taking oral contraceptives. The Journal of Obstetrics and Gynecology of the British Commonwealth77: 1007, 1970.
27.
Crane, M.G., Harris, J.J.: Effect of estrogens and gestagens on exchangeable sodium. In "Oral Contraceptives and High Blood Pressure", ( Fregly, M. J. and Fregly, M. S.) The Dolphin Press pp. 159-169, 1974.
Laragh, J.H. : Hormones and the pathogenesis of congestive heart failure: Vasopressin, aldosterone, and angiotensin II. Circulation25: 1015, 1962.
30.
Schalekamp, M.A.D.H., Schalekamp-Kuyken , M.P.A., deMoor-Fruytier, M., Meininger, Th., Vaandrager-Kranenburg, D.J., Birkenhager, W.H.: Interrelationships between blood pressure, renin, renin-substrate and blood volume in terminal renal failure. Clinical Science and Molecular Medicine45: 417, 1973.
31.
McAllister, R.G., Jr., VanWay, C.W., Dayani , K., Anderson, W.J., Temple, E., Michelakis, A.M., Coppage, W.S., Jr., Oates, J.A.: Malignant Hypertension: Effect of therapy on renin and aldosterone. Circulation Research28-29(suppl II): 160, 1971.
32.
Conn, J.W., Cohen, E.L., McDonald, W.J., Blough, W.M., Jr., Lucas, C.P., Mayor, G.H., Eveland, W.C., Bookstein, J.J., Lapides, J.: The syndrome of hypertension hyperreninemia and secondary aldosteronism associated with renal juxtaglomerular cell tumor. (Primary Reninism) Transaction of the American Association of Genito-Urinary Surgeons64: 47, 1972.
33.
Mitchell, J.D. , Baxter, T.J., Blair-West , J.R., McCredie, D.A.: Renin levels in nephroblastoma (Wilm's tumor). Report of a renin secreting tumor. Archives Dis. Child.45: 376, 1970.
34.
Brown, J.J. , Dusterdieck, G., Fraser , R., Lever, A.F., Robertson, J.I.S., Tree, M., Weir, R.J.: Hypertension and chronic renal failure. British MedicalBulletin27: 128, 1971.
35.
Conn, J.W.: Presidential address—Part I Painting backgrounds—Part II Primary Aldosteronism a new clinical syndrome. J. Lab. Clin. Med.45: 3, 1955.
36.
Biglieri, E.G. : Hypertension with primary and secondary hyperaldosteronism . Postgraduate Medicine52: 78, 1972.
37.
Biglieri, E.G. , Schambelam, M., Slaton , P.: The intercurrent hypertension of primary aldosteronism. Circulation Research26(suppl. I): 195, 1970.
38.
New, M.I., Siegal, E.J., Peterson, R.E.: Dexamethasone suppressible hyperaldosteronism. Journal of Clinical Endocrinology and Metabolism37: 93, 1973.
39.
Conn, J.W., Cohen, E.L., Rovner, D.R.: Suppression of plasma renin activity in primary aldosteronism. JAMA190: 213, 1964.
40.
Brown, J.J., Chinn, R.H., Davies, D.L., Dusterdieck, G., Fraser, R., Lever, A.F., Robertson, J.I.S., Tree, M.: Plasma electrolytes, renin, and aldosterone in the diagnosis of primary hyperaldosteronism . The Lancet2: 55, 1968.
41.
Jose, A., Kaplan, N.M.: Plasma renin activity in the diagnosis of primary aldosteronism: Failure to distinguish primary aldosteronism from essential hypertension. Archives ofInternal Medicine123: 141, 1969.
42.
Ledingham, J.G.G. , Bull, M.B., Laragh , J.H.: The meaning of aldosteronism in hypertensive disease. Circulation Research20-21(suppl II): 177, 1967.
43.
Espiner, E.A. , Christlieb, A.R., Amsterdam , E.A., Jagger, P.I., Dobrzinsky, S.J., Lauler, D.P., Hickler, R.B.: The pattern of plasma renin activity and aldosterone secretion in normal and hypertensive subjects before and after saline infusions. The American Journal of Cardiology27: 585, 1971.
44.
Kaplan, N.M. : Commentary on incidence of primary aldosteronism. Archives ofInternal Medicine123: 152, 1969 .
45.
Schalekamp, M.A.D.H., Schalekamp-Kuyken , M.P.A., Birkenhager, W.H.: Abnormal renal hemodynamics and renin suppression in hypertensive patients. Clinical Science38: 101, 1970.
46.
Melby, J.C. , Dale, S.L., Wilson , T.E.: 18-Hydroxy-deoxycorticosterone in human hypertension. Circulation Research28-29(suppl II): 143, 1971.
47.
Brown, J.J. , Ferriss, J.B., Fraser , R., Lever, A.F., Love, D.R., Robertson, J.I.S., Wilson, A.: Apparently isolated excess deoxycorticosterone in hypertension. The Lancet2: 243, 1972.
48.
Woods, J.W. , Hill, C., Liddle , G.W., Stant, E.G., Jr., Michelakis , A.M., Brill, A.B.: Effect of an adrenal inhibitor in hypertensive patients with suppressed renin. Archives of Internal Medicine123: 366, 1969.
49.
Crane, M.G. , Harris, J.J.: Effect of spironolactone in hypertensive patients. American Journal ofMed. Sci.260: 311, 1970 .
50.
Spark, R.F. , Melby, J.C.: Hypertension and low plasma renin activity: Presumptive evidence for mineralocorticoid excess. Annals of Internal Medicine75: 831, 1971.
51.
Jose, A., Crout, R.J., Kaplan, N.M.: Suppressed plasma renin activity in essential hypertension. Roles of plasma volume, blood pressure and sympathetic nervous system. Annals of Internal Medicine72: 9, 1970.
52.
Sennett, J., Brown, R., Island, D., Yarbio, L., Watson, J.T., Slaton, P., Hollifield, J., Liddle, G.: Evidence for a new mineralocorticoid in urine of certain patients with "low renin hypertension". Abstract, presented at the Council for High Blood Pressure Research of theAmerican Heart Association , Cleveland, Ohio, 1974.
53.
Grim, C., Winnacker, J., Peters, T., Gilbert, G.: Low renin "normal" aldosterone and hypertension: Circadian rhythm of renin, aldosterone, cortisol and growth hormone. J. Clin. Endocrin. & Metab.39: 247, 1974.
54.
Brown, J.J. , Lever, A.I., Robertson , J.I.S., Schalekamp , M.A.: Renal abnormality of essential hypertension. The Lancet2: 320, 1974.
Espiner, E.A. , Tucci, J.R., Jagger , P.I., Lauler, D.P.: Effect of saline infusions on aldosterone secretion and electrolyte excretion in normal subjects and patients with primary aldosteronism. The New England Journal of Medicine277: 1, 1967.
57.
Kem, D.C., Weinberger, M.H., Mayes, D.M., Nugent, C.A.: Saline suppression of plasma aldosterone in hypertension. Archives ofInternal Medicine128: 380, 1971.
Fisher, C.E. , Turner, F.A., Horton , R.: Remission of primary hyperaldosteronism after adrenal venography. The New England Journal of Medicine285: 334, 1971.
Liddle, G.W. , Bledsoe, T., Coppage, W.S., Jr.: A familial renal disorder simulating primary aldosteronism but with negligible aldosterone secretion. Trans. Assoc. Am. Physicians76: 199, 1963.
68.
Milora, R., Nagmucci, A., Godmann, A.D.: A syndrome resembling primary aldosteronism but without mineralocorticoid excess. Clinical Research15: 482, 1967.
69.
Brown, J.J., Davies, D.L., Lever, A.F., Robertson, J.I.S.: Plasma renin concentration in human hypertension. II. Renin in relation to etiology. British Med. Journal2: 1215, 1965.
70.
Goldsmith, O. , Solomon, D.H., Horton , R.: Hypogonadism and mineralocorticoid excess: The 17-hydroxylase deficiency syndrome. The New England Journal of Medicine277: 673, 1967.
71.
Kahn, M., Melby, J.C., Jacobs, D.: Isolated desoxycorticosterone excess: A unique syndrome simulating hyperaldosteronism . Clinical Research14: 282, 1966.
72.
Fraser, R., James, V.H.T., Landon, J., Peart, W.S., Rawson, A., Giles, C.S., McKay, A.M.: Clinical and biochemical studies of a patient with a corticosterone secreting adrenocortical tumor. The Lancet2: 1116, 1968.
73.
Genest, J., Nowaczynski, W.: Journal of the Royal College of Physicians of London5: 77, 1970.